We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
(Approval lapsed) AGUETTANT SODIUM VALPORATE 400mg/4mL, solution for injection
Section 19A approved medicine
(Approval lapsed) AGUETTANT SODIUM VALPORATE 400mg/4mL, solution for injection
Section 19A approval holder
Juno Pharmaceuticals Pty Ltd ABN 55 156 303 650
Phone
03 8888 1288
Approved until
Status
Expired
Medicines in short supply/unavailable
SODIUM VALPROATE JUNO sodium valproate 400 mg/4mL solution for injection, ampoule AUST R: 281241
SODIUM VALPROATE WOCKHARDT sodium valproate 400 mg/4 mL solution for injection ampoule AUST R: 279248
SODIUM VALPROATE WOCKHARDT sodium valproate 400 mg/4 mL solution for injection ampoule AUST R: 279248
Indication(s)
Sodium valproate is used for the treatment of patients with epilepsy or mania, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible.
Images
